Selective MAO-B inhibitors: a lesson from natural products

被引:119
作者
Carradori, Simone [1 ]
D'Ascenzio, Melissa [1 ]
Chimenti, Paola [1 ]
Secci, Daniela [1 ]
Bolasco, Adriana [1 ]
机构
[1] Univ Roma La Sapienza, Dept Drug Chem & Technol, I-00185 Rome, Italy
关键词
Alzheimer's disease; Depression; MAO inhibitor; Natural products; Neuroprotection; Parkinson's disease; MONOAMINE-OXIDASE-B; PARKINSONS-DISEASE; MOUSE-BRAIN; ANTIDEPRESSANT ACTIVITY; PIPER-LONGUM; A REACTION; IN-SILICO; CURCUMIN; QUERCETIN; BERBERINE;
D O I
10.1007/s11030-013-9490-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidases (MAOs) are mitochondrial bound enzymes, which catalyze the oxidative deamination of monoamine neurotransmitters. Inside the brain, MAOs are present in two isoforms: MAO-A and MAO-B. The activity of MAO-B is generally higher in patients affected by neurodegenerative diseases like Alzheimer's and Parkinson's. Therefore, the search for potent and selective MAO-B inhibitors is still a challenge for medicinal chemists. Nature has always been a source of inspiration for the discovery of new lead compounds. Moreover, natural medicine is a major component in all traditional medicine systems. In this review, we present the latest discoveries in the search for selective MAO-B inhibitors from natural sources. For clarity, compounds have been classified on the basis of structural analogy or source: flavonoids, xanthones, tannins, proanthocyanidins, iridoid glucosides, curcumin, alkaloids, cannabinoids, and natural sources extracts. MAO inhibition values reported in the text are not always consistent due to the high variability of MAO sources (bovine, pig, rat brain or liver, and human) and to the heterogeneity of the experimental protocols used.
引用
收藏
页码:219 / 243
页数:25
相关论文
共 122 条
  • [1] Abell CW, 2001, PROG NUCLEIC ACID RE, V65, P129
  • [2] CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES
    BACH, AWJ
    LAN, NC
    JOHNSON, DL
    ABELL, CW
    BEMBENEK, ME
    KWAN, SW
    SEEBURG, PH
    SHIH, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4934 - 4938
  • [3] Evaluation of the Inhibitory Effects of Quercetin-Related Flavonoids and Tea Catechins on the Monoamine Oxidase-A Reaction in Mouse Brain Mitochondria
    Bandaruk, Yauhen
    Mukai, Rie
    Kawamura, Tomoyuki
    Nemoto, Hisao
    Terao, Junji
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (41) : 10270 - 10277
  • [4] MONOAMINE-OXIDASE, BRAIN AGING AND DEGENERATIVE DISEASES
    BENEDETTI, MS
    DOSTERT, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) : 555 - 561
  • [5] MONOAMINE OXIDASE-INHIBITING ACTIVITY OF MANGIFERIN ISOLATED FROM CANSCORA-DECUSSATA
    BHATTACHARYA, SK
    SANYAL, AK
    GHOSAL, S
    [J]. NATURWISSENSCHAFTEN, 1972, 59 (12) : 651 - 651
  • [6] Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity
    Bi, Jing
    Wang, Xiao-bo
    Chen, Lei
    Hao, Shuang
    An, Li-jia
    Jiang, Bo
    Guo, Lei
    [J]. TOXICOLOGY IN VITRO, 2008, 22 (08) : 1883 - 1889
  • [7] Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane
    Binda, C
    Hubálek, F
    Li, M
    Edmondson, DE
    Mattevi, A
    [J]. FEBS LETTERS, 2004, 564 (03): : 225 - 228
  • [8] Blaschko H, 1937, J PHYSIOL-LONDON, V90, P1
  • [9] Recent development of monoamine oxidase inhibitors
    Bolasco, A
    Fioravanti, R
    Carradori, S
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (12) : 1763 - 1782
  • [10] Focusing on new monoamine oxidase inhibitors
    Bolasco, Adriana
    Carradori, Simone
    Fioravanti, Rossella
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (07) : 909 - 939